S. Caillères

Statistics

Publications

Citations

H-Index

Active since

1998

Affiliations

Centre Hospitalier Intercommunal Aix-Pertuis(Current)

S. Caillères is an author at Centre Hospitalier Intercommunal Aix-Pertuis specializing in pharmacotherapy, cancer immunotherapy, and immunotherapy safety.

Publications per year

1998–2023

Publications

E6a2BCR-ABLfusion withBCRexon 5-deleted transcript in a Philadelphia positive CML responsive to Imatinib

Cornel Popovici, S. Caillères, Martine David et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2005 · 24 citations

Life Sciences, Genetics, Molecular Biology +7

[Interferon alpha and pamidronate: a useful combination in the treatment of osteoporosis and systemic mastocytosis].

Brunel, Z Tadrist, S. Caillères et al. · PubMed · 1998 · 20 citations

Pharmacy, Pharmacotherapy, Bone Metabolism +8

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: the IFM 2020-04 study

Alexis Talbot, Arthur Bobin, Léa Tabone et al. · Haematologica · 2023 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Treatment of Philadelphia-Positive Acute Lymphocytic Leukemia (Ph+ ALL) in the Elderly with Imatinib Mesylate (STI571) and Chemotherapy.

André Delannoy, Véronique Lhéritier, Xavier Thomas et al. · Blood · 2005 · 14 citations

Medicine, Oncology, Pharmacotherapy +11

Adverse Events Induced by PD-1/PD-L1 Inhibitors: A Real-World Single-Centre Experience with a Management-Based Approach

F. Grimaud, Guillaume Pénaranda, C. Stavris et al. · Therapeutics and Clinical Risk Management · 2021 · 13 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–5 of 5